Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1986 Jul;39(7):713–716. doi: 10.1136/jcp.39.7.713

Autoimmunity in chronic lymphocytic leukaemia.

T J Hamblin, D G Oscier, B J Young
PMCID: PMC500029  PMID: 3488334

Abstract

The prevalence of autoantibodies in B cell chronic lymphocytic leukaemia (B-CLL) was investigated. A lower prevalence of autoimmune haemolytic anaemia than that found in other series was found: large numbers of non-progressive stage A disease cases were included, in which the prevalence of autoimmune haemolytic anaemia is low. Non-haematological autoantibodies were no commoner than in age matched controls. Whatever explanation is offered for autoimmune phenomena in B-CLL it must take account of the fact that those phenomena are virtually confined to autoantibodies against the formed elements of the blood.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abeloff M. D., Waterbury L. Pure red blood cell aplasia and chronic lymphocytic leukemia. Arch Intern Med. 1974 Oct;134(4):721–724. [PubMed] [Google Scholar]
  2. Bergsagel D. E. The chronic leukemias: a review of disease manifestations and the aims of therapy. Can Med Assoc J. 1967 Jun 24;96(25):1615–1620. [PMC free article] [PubMed] [Google Scholar]
  3. Catovsky D., Lauria F., Matutes E., Foa R., Mantovani V., Tura S., Galton D. A. Increase in T gamma lymphocytes in B-cell chronic lymphocytic leukaemia. II. Correlation with clinical stage and findings in B-prolymphocytic leukaemia. Br J Haematol. 1981 Apr;47(4):539–544. doi: 10.1111/j.1365-2141.1981.tb02682.x. [DOI] [PubMed] [Google Scholar]
  4. Chronic lymphocytic leukaemia: proposals for a revised prognostic staging system. Report from the International Workshop on CLL. Br J Haematol. 1981 Jul;48(3):365–367. doi: 10.1111/j.1365-2141.1981.tb02727.x. [DOI] [PubMed] [Google Scholar]
  5. EBBE S., WITTELS B., DAMESHEK W. Autoimmune thrombocytopenic purpura ("ITP" type) with chronic lymphocytic leukemia. Blood. 1962 Jan;19:23–37. [PubMed] [Google Scholar]
  6. Goodnough L. T., Muir W. A. Bullous pemphigoid as a manifestation of chronic lymphocytic leukemia. Arch Intern Med. 1980 Nov;140(11):1526–1527. [PubMed] [Google Scholar]
  7. Hansen M. M. Chronic lymphocytic leukaemia. Clinical studies based on 189 cases followed for a long time. Scand J Haematol Suppl. 1973;18:3–286. [PubMed] [Google Scholar]
  8. Kay N. E. Abnormal T-cell subpopulation function in CLL: excessive suppressor (T gamma) and deficient helper (T mu) activity with respect to B-cell proliferation. Blood. 1981 Mar;57(3):418–420. [PubMed] [Google Scholar]
  9. Lewis F. B., Schwartz R. S., Dameshek W. X-radiation and alkylating agents as possible "trigger" mechanisms in the autoimmune complications of malignant lymphophroliferative disease. Clin Exp Immunol. 1966 Jan;1(1):3–11. [PMC free article] [PubMed] [Google Scholar]
  10. Mangan K. F., D'Alessandro L. Hypoplastic anemia in B cell chronic lymphocytic leukemia: evolution of T cell-mediated suppression of erythropoiesis in early-stage and late-stage disease. Blood. 1985 Sep;66(3):533–541. [PubMed] [Google Scholar]
  11. Parker A. C., Bennett M. Pernicious anaemia and lymphoproliferative disease. Scand J Haematol. 1976 Nov;17(5):395–397. doi: 10.1111/j.1600-0609.1976.tb01450.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES